Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.21 (
CPT
)
4,580
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Five genes in the human genome are known to encode different active forms of related carnitine acyltransferases: CPT1A for liver-type
carnitine palmitoyltransferase I
, CPT1B for muscle-type
carnitine palmitoyltransferase I
, CPT2 for
carnitine palmitoyltransferase II
,
CROT
for carnitine octanoyltransferase, and CRAT for carnitine acetyltransferase. Only from two of these genes (CPT1B and CPT2) have full genomic structures been described. Data from the human genome sequencing efforts now reveal drafts of the genomic structure of CPT1A and CRAT, the latter not being known from any other mammal. Furthermore, cDNA sequences of human
CROT
were obtained recently, and database analysis revealed a completed bacterial artificial chromosome sequence that contains the entire
CROT
gene and several exons of the flanking genes P53TG and PGY3. The genomic location of
CROT
is at chromosome 7q21.1. There is a putative CPT1-like pseudogene in the carnitine/choline acyltransferase family at chromosome 19. Here we give a brief overview of the functional relations between the different carnitine acyltransferases and some of the common features of their genes. We will highlight the phylogenetics of the human carnitine acyltransferase genes in relation to the fungal genes YAT1 and CAT2, which encode cytosolic and mitochondrial/peroxisomal carnitine acetyltransferases, respectively.
...
PMID:Genomics of the human carnitine acyltransferase genes. 1100 5